265 related articles for article (PubMed ID: 17355968)
1. The NOD2-RICK complex signals from the plasma membrane.
Lécine P; Esmiol S; Métais JY; Nicoletti C; Nourry C; McDonald C; Nunez G; Hugot JP; Borg JP; Ollendorff V
J Biol Chem; 2007 May; 282(20):15197-207. PubMed ID: 17355968
[TBL] [Abstract][Full Text] [Related]
2. RNAi screening identifies mediators of NOD2 signaling: implications for spatial specificity of MDP recognition.
Lipinski S; Grabe N; Jacobs G; Billmann-Born S; Till A; Häsler R; Aden K; Paulsen M; Arlt A; Kraemer L; Hagemann N; Erdmann KS; Schreiber S; Rosenstiel P
Proc Natl Acad Sci U S A; 2012 Dec; 109(52):21426-31. PubMed ID: 23213202
[TBL] [Abstract][Full Text] [Related]
3. Muramyl Dipeptide Enhances Thermal Injury-Induced Autophagy and Inflammatory Cytokine Response of Lungs via Activation of NOD2/Rick Signaling Pathway in Rats.
Wu XJ; Liang H; Zhang Y; Yang XM; Wang HY; Li H; Li XY; Chen K; Wang YL; Li JG; Zhang ZZ; Song XM
Shock; 2018 Nov; 50(5):606-612. PubMed ID: 29215417
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Salmonella flagellin-induced interleukin-8 in intestinal epithelial cells by muramyl dipeptide.
Huang FC
Cell Immunol; 2012; 278(1-2):1-9. PubMed ID: 23121969
[TBL] [Abstract][Full Text] [Related]
5. TAK1 is a central mediator of NOD2 signaling in epidermal cells.
Kim JY; Omori E; Matsumoto K; Núñez G; Ninomiya-Tsuji J
J Biol Chem; 2008 Jan; 283(1):137-144. PubMed ID: 17965022
[TBL] [Abstract][Full Text] [Related]
6. Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-{kappa}B activation in muramyl dipeptide recognition.
Barnich N; Aguirre JE; Reinecker HC; Xavier R; Podolsky DK
J Cell Biol; 2005 Jul; 170(1):21-6. PubMed ID: 15998797
[TBL] [Abstract][Full Text] [Related]
7. Nod2-Rip2 Signaling Contributes to Intestinal Injury Induced by Muramyl Dipeptide Via Oligopeptide Transporter in Rats.
Ma G; Shi B; Liu J; Zhang H; YinTao Z; Lou X; Liang D; Hou Y; Wan S; Yang W
Dig Dis Sci; 2015 Nov; 60(11):3264-70. PubMed ID: 26138652
[TBL] [Abstract][Full Text] [Related]
8. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations.
Li J; Moran T; Swanson E; Julian C; Harris J; Bonen DK; Hedl M; Nicolae DL; Abraham C; Cho JH
Hum Mol Genet; 2004 Aug; 13(16):1715-25. PubMed ID: 15198989
[TBL] [Abstract][Full Text] [Related]
9. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation.
Hasegawa M; Fujimoto Y; Lucas PC; Nakano H; Fukase K; Núñez G; Inohara N
EMBO J; 2008 Jan; 27(2):373-83. PubMed ID: 18079694
[TBL] [Abstract][Full Text] [Related]
10. The molecular chaperone HSP70 binds to and stabilizes NOD2, an important protein involved in Crohn disease.
Mohanan V; Grimes CL
J Biol Chem; 2014 Jul; 289(27):18987-98. PubMed ID: 24790089
[TBL] [Abstract][Full Text] [Related]
11. Crohn's Disease Variants of Nod2 Are Stabilized by the Critical Contact Region of Hsp70.
Schaefer AK; Wastyk HC; Mohanan V; Hou CW; Lauro ML; Melnyk JE; Burch JM; Grimes CL
Biochemistry; 2017 Aug; 56(34):4445-4448. PubMed ID: 28792733
[TBL] [Abstract][Full Text] [Related]
12. ITCH K63-ubiquitinates the NOD2 binding protein, RIP2, to influence inflammatory signaling pathways.
Tao M; Scacheri PC; Marinis JM; Harhaj EW; Matesic LE; Abbott DW
Curr Biol; 2009 Aug; 19(15):1255-63. PubMed ID: 19592251
[TBL] [Abstract][Full Text] [Related]
13. MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.
Cantó E; Moga E; Ricart E; Garcia-Bosch O; Garcia-Planella E; Juarez C; Vidal S
Inflamm Bowel Dis; 2009 Nov; 15(11):1686-96. PubMed ID: 19572373
[TBL] [Abstract][Full Text] [Related]
14. Characterization and Genetic Analyses of New Genes Coding for NOD2 Interacting Proteins.
Thiébaut R; Esmiol S; Lecine P; Mahfouz B; Hermant A; Nicoletti C; Parnis S; Perroy J; Borg JP; Pascoe L; Hugot JP; Ollendorff V
PLoS One; 2016; 11(11):e0165420. PubMed ID: 27812135
[TBL] [Abstract][Full Text] [Related]
15. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2.
Yang Y; Yin C; Pandey A; Abbott D; Sassetti C; Kelliher MA
J Biol Chem; 2007 Dec; 282(50):36223-9. PubMed ID: 17947236
[TBL] [Abstract][Full Text] [Related]
16. Identification of MDP (muramyl dipeptide)-binding key domains in NOD2 (nucleotide-binding and oligomerization domain-2) receptor of Labeo rohita.
Maharana J; Swain B; Sahoo BR; Dikhit MR; Basu M; Mahapatra AS; Jayasankar P; Samanta M
Fish Physiol Biochem; 2013 Aug; 39(4):1007-23. PubMed ID: 23255217
[TBL] [Abstract][Full Text] [Related]
17. Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP.
Mo J; Boyle JP; Howard CB; Monie TP; Davis BK; Duncan JA
J Biol Chem; 2012 Jun; 287(27):23057-67. PubMed ID: 22549783
[TBL] [Abstract][Full Text] [Related]
18. NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6.
Watanabe T; Asano N; Meng G; Yamashita K; Arai Y; Sakurai T; Kudo M; Fuss IJ; Kitani A; Shimosegawa T; Chiba T; Strober W
Mucosal Immunol; 2014 Nov; 7(6):1312-25. PubMed ID: 24670424
[TBL] [Abstract][Full Text] [Related]
19. Nod2-Nodosome in a Cell-Free System: Implications in Pathogenesis and Drug Discovery for Blau Syndrome and Early-Onset Sarcoidosis.
Iwasaki T; Kaneko N; Ito Y; Takeda H; Sawasaki T; Heike T; Migita K; Agematsu K; Kawakami A; Morikawa S; Mokuda S; Kurata M; Masumoto J
ScientificWorldJournal; 2016; 2016():2597376. PubMed ID: 27403452
[TBL] [Abstract][Full Text] [Related]
20. Blau syndrome-associated Nod2 mutation alters expression of full-length NOD2 and limits responses to muramyl dipeptide in knock-in mice.
Dugan J; Griffiths E; Snow P; Rosenzweig H; Lee E; Brown B; Carr DW; Rose C; Rosenbaum J; Davey MP
J Immunol; 2015 Jan; 194(1):349-57. PubMed ID: 25429073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
